CLEAN Clean Science and Technology Q4 FY26 results (Jan–Mar 2026) and concall
Clean Science reported a resilient Q4 FY26 with sequential improvements in standalone revenue and strong performance in its HALS business, which achieved its highest ever revenue. The Clean Fino-Chem subsidiary turned EBITDA positive. Despite persistent global challenges, including muted customer off-take and pricing pressures, the company declared a final dividend and saw promoter directors forgo a significant portion of their bonus. Strategic initiatives like HALS capacity expansion and backward integration are underway, though the FY27 outlook remains cautious due to macro uncertainties.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 5.7%, net profit down 21.6% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 238 | 241 | 264 | 243 | 245 +3% | 220 −9% | 249 −6% |
| EBITDA | 90 | 98 | 105 | 100 | 87 −3% | 72 −27% | 96 −9% |
| Net profit | 59 | 66 | 74 | 70 | 55 −7% | 46 −30% | 58 −22% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





